Compare COLL & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COLL | CASH |
|---|---|---|
| Founded | 2002 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | N/A |
| Metric | COLL | CASH |
|---|---|---|
| Price | $45.38 | $86.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $51.17 | ★ $91.00 |
| AVG Volume (30 Days) | ★ 512.5K | 231.7K |
| Earning Date | 02-26-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | ★ 26.63 |
| EPS | 1.63 | ★ 8.26 |
| Revenue | $757,067,000.00 | ★ $786,023,000.00 |
| Revenue This Year | $26.17 | $10.95 |
| Revenue Next Year | $3.65 | $4.75 |
| P/E Ratio | $28.19 | ★ $10.34 |
| Revenue Growth | ★ 26.34 | 10.54 |
| 52 Week Low | $23.23 | $64.45 |
| 52 Week High | $50.79 | $86.92 |
| Indicator | COLL | CASH |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 75.55 |
| Support Level | $44.43 | $73.73 |
| Resistance Level | $48.29 | $86.92 |
| Average True Range (ATR) | 2.15 | 2.09 |
| MACD | -0.25 | 1.30 |
| Stochastic Oscillator | 31.27 | 95.62 |
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.